findmyKOL
Clinical trialNCT00016068CompletedPhase 3Interventional

Valganciclovir to Prevent Cytomegalovirus Infection in Patients Following Donor Stem Cell Transplantation

SponsorFred Hutchinson Cancer CenterEnrollment184Infection
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • City of Hope Comprehensive Cancer Center

    Duarte, California, United States

  • University of Florida Shands Cancer Center

    Gainesville, Florida, United States

  • Barbara Ann Karmanos Cancer Institute

    Detroit, Michigan, United States

  • Mayo Clinic Cancer Center

    Rochester, Minnesota, United States

  • Memorial Sloan-Kettering Cancer Center

    New York, New York, United States

  • M.D. Anderson Cancer Center at University of Texas

    Houston, Texas, United States

  • Fred Hutchinson Cancer Research Center

    Seattle, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Jan 2001
Primary completion
Completion
30 Sept 2007
Last update posted
17 May 2010
Registered enrollment
184
Registry id
NCT00016068

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.